Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.11 Million ≈ $6.60 Million USD) by net assets (CN¥1.88 Billion ≈ $274.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Shandong Bailong Chuangyuan Bio-Tech Co. for a breakdown of total debt and financial obligations.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TECNOGLASS INC. DL-0001
F:7FH
|
0.043x |
|
Winpak Ltd.
TO:WPK
|
0.053x |
|
Chengdu ALD Aviation Manufacturing Corp
SHE:300696
|
-0.006x |
|
Kyland Technology Co Ltd
SHE:300353
|
-0.023x |
|
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd A
SHG:600648
|
0.009x |
|
Louis HachEtte Group SA
PA:ALHG
|
0.162x |
|
Sixth Street Specialty Lending Inc
NYSE:TSLX
|
-0.010x |
|
PT Super Bank Indonesia Tbk
JK:SUPA
|
0.298x |
Annual Cash Flow Conversion Efficiency for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2024)
The table below shows the annual cash flow conversion efficiency of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Shandong Bailong Chuangyuan Bio-Tech Co. market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.68 Billion ≈ $245.73 Million |
CN¥300.89 Million ≈ $44.03 Million |
0.179x | +38.81% |
| 2023-12-31 | CN¥1.51 Billion ≈ $220.64 Million |
CN¥194.63 Million ≈ $28.48 Million |
0.129x | +15.88% |
| 2022-12-31 | CN¥1.34 Billion ≈ $196.81 Million |
CN¥149.82 Million ≈ $21.92 Million |
0.111x | +39.36% |
| 2021-12-31 | CN¥1.20 Billion ≈ $176.10 Million |
CN¥96.20 Million ≈ $14.08 Million |
0.080x | -54.65% |
| 2020-12-31 | CN¥691.09 Million ≈ $101.13 Million |
CN¥121.82 Million ≈ $17.83 Million |
0.176x | +64.25% |
| 2019-12-31 | CN¥597.07 Million ≈ $87.37 Million |
CN¥64.08 Million ≈ $9.38 Million |
0.107x | -39.58% |
| 2018-12-31 | CN¥501.71 Million ≈ $73.42 Million |
CN¥89.12 Million ≈ $13.04 Million |
0.178x | -31.68% |
| 2017-12-31 | CN¥436.41 Million ≈ $63.86 Million |
CN¥113.47 Million ≈ $16.60 Million |
0.260x | +56.90% |
| 2016-12-31 | CN¥362.67 Million ≈ $53.07 Million |
CN¥60.10 Million ≈ $8.79 Million |
0.166x | -- |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more